Sibylla Biotech S.p.A. news

Sibylla PPI-FIT technology identifies novel druggable pockets in the intermediate folding states of proteins

Sibylla intends to market the PPI-FIT technology platform-as-a-service‚ to the biotechnology and pharmaceutical industries. It also plans to generate its own in-house proprietary pipeline

Verona (Italy), May 18th 2021 – Sibylla Biotech announced a research collaboration with Takeda Pharmaceutical Company Limited to discover novel small molecules that modu